Twinbeech Capital LP Bio Xcel Therapeutics, Inc. Transaction History

Twinbeech Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$23.84 - $32.03 $208,600 - $280,262	-8,750 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.06 - $38.83 $254,275 - $339,762	8,750 New	8,750 $254,000
Q1 2021 May 17, 2021	SELL	$39.04 - $64.6 $176,109 - $291,410	-4,511 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$42.46 - $56.58 $191,537 - $255,232	4,511 New	4,511 $208,000

3.13M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.53M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.